跳到内容
hiliver.cn学术分享

学术分享

  • 使用手册
  • 常用静脉泵入药物
  • 门诊常用ICD编码
  • 指南&共识
  • 临床工具
  • 关于
login
hiliver.cn学术分享

学术分享

登录
未分类

Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohort

作者Dr_HanF 2023-05-292023-05-29

Kali Zhou 1 2, Tiffany Lim 1, …

阅读更多 Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohort继续

未分类

Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

作者Dr_LiP 2023-05-292023-05-29

Chiara Rosso 1, Gian Paolo Caviglia 1,&n…

阅读更多 Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease继续

未分类

Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis

作者Dr_LiW 2023-05-292023-05-29

Kavish R Patidar 1, Mobasshir A Naved 2,…

阅读更多 Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis继续

未分类

Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis

作者Dr_MaYH 2023-05-292023-05-29

Veeral Ajmera 1 2, Na Wang 3, Hanfei Xu 4, Ching-Ti Liu…

阅读更多 Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis继续

未分类

The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease

作者Dr_WangLL 2023-05-292023-05-29

Zobair M Younossi 1 2 3, Maria Step…

阅读更多 The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease继续

内分泌代谢疾病|指南与共识

中国血脂管理指南(2023年)

作者Dr_F_LIU 2023-05-242023-05-24

中华心血管病杂志, 2023,51(3) : 221-255. DOI: 10.3760/cma.j…

阅读更多 中国血脂管理指南(2023年)继续

页面导航

上一页上一页 1 2 3 4 5 … 20 下一页下一页

2018年修订版 2021 2022 ACLF AIH CNN ELM PBC SVM UDCA 临床治愈 乙肝 二级预防 人工智能 他汀 低分子肝素 保肝 免疫调节剂 减重 利伐沙班 利拉鲁肽 吸烟 围手术期 干扰素 抗凝 抗血栓 指南 桥接 溶栓 特利加压素 糖尿病 肝病 肝癌 肝硬化 肝纤维化 肝肿瘤 胆血症 脂肪肝 药物 运动 门脉血栓 防治指南 静脉曲张 饮食 高血压

TikTok Github Instagram Facebook Twitter

备案号:津ICP备2022007313号

© 2026 hiliver.cn学术分享

滚动到顶部
  • 使用手册
  • 常用静脉泵入药物
  • 门诊常用ICD编码
  • 指南&共识
  • 临床工具
  • 关于
搜索